Posts Tagged ‘heart failure’

August 28th, 2014

Predicting PARADIGM-HF, or What to Expect When You’re Expecting

Larry Husten analyzes the expectations surrounding the upcoming release of PARADIGM-HF and its centerpiece LCZ696 from the perspective of the medical field as well as the world of economics.


August 18th, 2014

Selections from Richard Lehman’s Literature Review: August 18th

This week’s topics include the three sodium studies from NEJM, the CLARIFY study, and more.


August 14th, 2014

The CardioMEMS HF System: What Do You Say to Your Patient?

In this scenario based on a patient’s question about the CardioMEMS device, John Ryan asks, “What do you say to your patient?”


August 7th, 2014

How Should We Evaluate Hospital Care?

Dr. Xiao Xu weighs in on the question of how we should quantify the cost-effectiveness of hospital care.


July 29th, 2014

Cardiac Rehab for Heart Failure Patients: The CMS Is Convinced — Are You?

and

John Ryan interviews Dr. Ileana Piña about her work in HF-ACTION as it relates to the CMS’s recent expansion of cardiac rehabilitation coverage.


June 16th, 2014

Selections from Richard Lehman’s Literature Review: June 16th

This week’s topics include statins and physical activity in older men, transitional care interventions to prevent heart-failure readmissions, and more.


April 14th, 2014

Selections from Richard Lehman’s Literature Review: April 14th

This week’s topics include TOPCAT, fibrinolysis for those with intermediate-risk PE, and more.


April 9th, 2014

Putting TOPCAT in Perspective

, and

TOPCAT investigators Bertram Pitt and Marc Pfeffer discuss the trial, and Clyde Yancy offers his analysis.


April 7th, 2014

Selections from Richard Lehman’s Literature Review: April 7th

This week’s topics include SYMPLICITY HTN-3, CoreValve, MADIT-CRT, and more.


March 30th, 2014

Long-Term Follow-Up from MADIT-CRT: Guideline Implications

Arthur J. Moss discusses his research group’s study of long-term survival for patients who received cardiac resynchronization therapy with a defibrillator in the MADIT-CRT trial.